Investors



SEC Filings

Filing date Form Description Filing Group View
SC 13G/A

An amendment to the SC 13G filing

3,4,5
View HTML
S-8

Securities offered to employees pursuant to employee benefit plans

Registration Statements
View HTML
F-3

Registration statement for certain foreign private issuers offered for certain transactions

Registration Statements
View HTML
6-K

Report of foreign issuer rules 13a-16 and 15d-16 of the Securities Exchange Act

Current Reports
View HTML
SC 13G

A statement of beneficial ownership of common stock by certain persons

3,4,5
View HTML
SC 13D/A

An amendment to a SC 13D filing

3,4,5
View HTML
6-K

Report of foreign issuer rules 13a-16 and 15d-16 of the Securities Exchange Act

Current Reports
View HTML
6-K

Report of foreign issuer rules 13a-16 and 15d-16 of the Securities Exchange Act

Current Reports
View HTML
6-K

Report of foreign issuer rules 13a-16 and 15d-16 of the Securities Exchange Act

Current Reports
View HTML
SC 13D

Filing by person(s) reporting owned shares of common stock in a public company >5%

3,4,5
View HTML

Copyright Morningstar







© 2018 Strongbridge Biopharma plc
STRONGBRIDGE BIOPHARMA® is a registered trademark of the Strongbridge Biopharma plc. companies, which include Strongbridge Ireland Limited and Strongbridge U.S. Inc.
KEVEYIS® is a registered trademark licensed exclusively in the U.S. to Strongbridge Biopharma plc.
MACRILEN is a trademark of Aeterna Zentaris GmbH, licensed exclusively in the U.S. and Canada to Strongbridge Ireland Limited.
MLR-0010 V13 01/2018

900 Northbrook Drive, Suite 200
Trevose, PA 19053
United States
Phone: +1 610-254-9200
info@strongbridgebio.com

Privacy Statement
Comprehensive Compliance Program
California Statement of Compliance